#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	17894	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2085	851.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1411	1411	C	1047	C,G	953,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	17894	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2085	851.8	0	HET	.	.	.	C207T,G	.	207	207	C	434	434	C	1040	C,T,G	548,379,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	17894	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2085	851.8	0	HET	.	.	.	C451T	.	451	451	C	678	678	C	1060	C,T	773,204	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32708	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3535	921.6	0	.	n	.	0	T695C	SNP	695	695	T	1057	1057	C	967	C,A	899,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32708	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3535	921.6	0	.	n	.	0	A1638G	SNP	1638	1638	A	2000	2000	G	974	G,A	350,544	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32708	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3535	921.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2333	2333	C	1113	C,T	989,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32708	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3535	921.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2407	2407	A	1019	A	940	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32708	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3535	921.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2959	2959	C	1043	C,T	962,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32708	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3535	921.6	0	HET	.	.	.	G1337A	.	1337	1337	G	1699	1699	G	1117	G,A	808,200	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2502	folP	855	855	100.0	folP.l15.c4.ctg.1	1468	169.3	1	SNP	p	R229S	1	.	.	685	687	AGC	996	998	AGC	270;269;270	A,G;G;C	240,1;240;239	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	283	6720	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3484	192.4	1	SNP	p	S91F	1	.	.	271	273	TTC	602	604	TTC	206;205;211	T;T;C	190;189;194	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	283	6720	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3484	192.4	1	SNP	p	G95N	0	.	.	283	285	GGC	614	616	GGC	214;212;211	G;G;C	201;201;195	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	283	6720	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3484	192.4	1	SNP	p	D95G	1	.	.	283	285	GGC	614	616	GGC	214;212;211	G;G;C	201;201;195	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	2152	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1281	167.0	1	SNP	p	G45D	0	.	.	133	135	GGC	501	503	GGC	271;270;269	G;G;C	242;245;240	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1010	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	1007	99.6	0	.	n	.	0	A197.	DEL	197	197	A	609	609	A	235	A	215	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6890	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3126	220.0	1	SNP	p	D86N	0	.	.	256	258	GAC	676	678	GAC	295;301;304	G;A;C	264;263;273	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6890	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3126	220.0	1	SNP	p	R87W	0	.	.	259	261	CGT	679	681	CGT	302;302;307	C;G;T	272;271;271	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6890	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3126	220.0	1	SNP	p	S87R	1	.	.	259	261	CGT	679	681	CGT	302;302;307	C;G;T	272;271;271	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6890	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3126	220.0	1	SNP	p	R87I	0	.	.	259	261	CGT	679	681	CGT	302;302;307	C;G;T	272;271;271	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6890	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3126	220.0	1	SNP	p	S88P	0	.	.	262	264	TCC	682	684	TCC	311;319;321	T;C,T;C	275;283,1;284	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5722	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2499	227.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1498	1500	GGC	275;271;276	G;G;C	257;251;255	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	5036	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2563	196.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1385	1387	GCC	272;274;273	G;C;C	252;255;253	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5036	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2563	196.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1388	1390	ATG	270;270;270	A,T;T;G	249,1;253;252	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5036	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2563	196.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1400	1402	ACC	257;255;254	A;C;C	236;237;237	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5036	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2563	196.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1400	1402	ACC	257;255;254	A;C;C	236;237;237	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5036	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2563	196.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1901	1903	ACC	271;273;277	A,G;C;C	232,1;241;247	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5036	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2563	196.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1955	1957	GCG	294;294;293	GC,GCC;C,G;G	275,1;273,1;274	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5036	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2563	196.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1955	1957	GCG	294;294;293	GC,GCC;C,G;G	275,1;273,1;274	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5036	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2563	196.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2078	2080	GGT	237;241;242	G;G;T	214;213;210	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5036	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2563	196.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2087	2089	AGC	232;228;226	A;G;C	198;198;197	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5036	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2563	196.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2105	2107	CCG	205;205;199	C,G;C;G	153,10;156;148	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6704	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3140	212.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1572	1574	CCG	292;291;288	C;C;G,C	257;263;254,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3532	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1767	198.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	526	526	C	262	C,G	236,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	320	porB1a	984	297	91.03	porB1a.l15.c30.ctg.2	351	39.4	0	.	p	.	0	H217N	NONSYN	649	651	CAT	74	76	AAT	16;16;16	A;A;T	14;14;14	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	320	porB1a	984	297	91.03	porB1a.l15.c30.ctg.2	351	39.4	0	.	p	.	0	D218N	NONSYN	652	654	GAT	77	79	AAT	19;19;20	A;A;T	17;17;18	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	320	porB1a	984	297	91.03	porB1a.l15.c30.ctg.2	351	39.4	0	.	p	.	0	V226A	NONSYN	676	678	GTA	101	103	GCA	22;22;22	G;C;A	22;22;22	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	320	porB1a	984	297	91.03	porB1a.l15.c30.ctg.2	351	39.4	0	.	p	.	0	.	MULTIPLE	700	702	ACT	124	126	GTA	18;19;19	G;T;A	18;19;19	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	320	porB1a	984	297	91.03	porB1a.l15.c30.ctg.2	351	39.4	0	.	p	.	0	N237fs	FSHIFT	709	709	A	133	133	A	20	A	20	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	667	3264	porB1b	1038	1038	99.9	porB1b.l6.c30.ctg.1	1544	209.5	0	.	p	.	0	I45V	NONSYN	133	135	ATT	492	494	GTT	254;257;260	G,A;T;T	197,38;232;235	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	667	3264	porB1b	1038	1038	99.9	porB1b.l6.c30.ctg.1	1544	209.5	1	SNP	p	G120K	1	.	.	358	360	AAG	717	719	AAG	282;281;279	A;A;G	259;259;256	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	667	3264	porB1b	1038	1038	99.9	porB1b.l6.c30.ctg.1	1544	209.5	1	SNP	p	A121N	1	.	.	361	363	AAC	720	722	AAC	280;282;280	A;A;C	260;260;260	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	667	3264	porB1b	1038	1038	99.9	porB1b.l6.c30.ctg.1	1544	209.5	1	SNP	p	N121D	0	.	.	361	363	AAC	720	722	AAC	280;282;280	A;A;C	260;260;260	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12356	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4876	252.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1310	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	985	132.0	1	SNP	p	V57M	1	.	.	169	171	ATG	515	517	ATG	288;289;291	A;T;G	261;263;265	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
